Investors
Directors’ Dealings
Share Dealings of Members of the Board of Executive Directors and the Supervisory Board
(Directors’ dealings to be notified and publicly disclosed under Article 19(1) of the EU Market Abuse Regulation 596/2014 (MAR))
As legally stipulated by Article 19(1) MAR, all members of the Board of Executive Directors and the Supervisory Board as well as close family relatives are required to disclose the purchase or sale of financial instruments of BASF SE (for example, shares, bonds, options, forward contracts, swaps) to the German Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht) and to the company if transactions within the calendar year exceed the threshold of €50,000.
Share Ownership by Members of the Board of Executive Directors and the Supervisory Board
No member of the Board of Executive Directors or the Supervisory Board owns shares in BASF SE and related options or other derivatives that account for 1% or more of the share capital. Furthermore, the total volume of BASF SE shares and related financial instruments held by all members of the Board of Executive Directors and the Supervisory Board accounts for less than 1% of the shares issued by the company.
Closed periods
30 calendar days before public disclosure of a quarterly statement on the first or third quarter, half-year financial report or annual report of BASF SE.
Next closed periods:
-
June 29, 2026 to July 29, 2026
-
September 28, 2026 to October 28, 2026
-
January 27, 2027 to February 26, 2027
-
March 30, 2027 to April 29, 2027
Managers’ transactions
| Name | Date and Place of Transaction | Type of Transaction | Price per Item | Total Amount/ Currency | Reason for Disclosure Requirement/ Position | Description of Financial Instrument | ISIN |
|
Dr. Dirk Elvermann |
05/08/2026 Tradegate |
Purchase |
€50.91 |
€45,819.00 |
Board Member | Shares of BASF SE |
DE000BASF111 |
|
Dr. Kurt Bock |
05/04/2026 Xetra |
Purchase |
€53.63 |
€124,950.91 |
Supervisory Board Member | Shares of BASF SE | DE000BASF111 |
|
Prof. Dr. Stefan Asenkerschbaumer |
05/04/2026 Xetra |
Purchase |
€53.63 |
€74,970.55 |
Supervisory Board Member | Shares of BASF SE | DE000BASF111 |
|
Dr. Katja Scharpwinkel |
05/04/2026 Xetra |
Purchase |
€52.79 |
€211,160.00 |
Board Member | Shares of BASF SE |
DE000BASF111 |
|
Dr. Stephan Kothrade |
05/04/2026 Tradegate |
Purchase |
€54.00 |
€107,996.00 |
Board Member | Shares of BASF SE |
DE000BASF111 |